Clinical Trial Update: Effect of Fu's Subcutaneous Needling for Age-related Macular Degeneration [EARLY_Phase 1]

View source ↗

Summary

A clinical trial update notes that a Phase 1 study of Fu's Subcutaneous Needling for age-related macular degeneration is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Drugs mentioned

• Fu's Subcutaneous Needling

Snippet

Sponsor: Zhiming Yan | Conditions: Age - Related Macular Degeneration (AMD) | EARLY_Phase 1 | Status: NOT_YET_RECRUITING